ESTHERLINE EXUME-NOEL: Open Payments
NPI 1437518933 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 26 payments from 13 companies in 2025. Trend: 2023 $102 · 2024 $1,096 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $213 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| ABBVIE INC. | 3 | $66 |
| Lundbeck LLC | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Lilly USA, LLC | 1 | $29 |
| Corcept Therapeutics | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Bausch Health US, LLC | 1 | $20 |
Products named: REXULTI, FANAPT, UBRELVY, SPRAVATO, ZEPBOUND, HETLIOZ, Korlym, CAPLYTA.
Industry payments across FL — which companies pay providers there.
